Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Analysis, Inspection and Laboratory
LeftNav
Assisted/Independent Living
LeftNav
Clinical and Nursing Equipment
LeftNav
Design and Manufacture of Medical Equipment
LeftNav
Diagnostics Equipment, Monitoring and Test
LeftNav
Education, Training and Professional Services
LeftNav
Health Education and Patient Management
LeftNav
Health Estates Management
LeftNav
Healthcare Support and Information Services
LeftNav
Hygiene and Infection Control
LeftNav
IT and Communications in Healthcare
LeftNav
Materials
LeftNav
Medical Device Technology
LeftNav
Research and Development
LeftNav
Safety and Security
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
News

Swansea University researches breath test for cancer and diabetes

Swansea University School Of Health Science : 11 February, 2008  (New Product)
Swansea University researchers are using state-of-the-art equipment to develop a breath test for diagnosing diseases including diabetes and cancer.
Dr Masood Yousef ,a senior research assistant in the Welsh Centre for Printing and Coating, which is housed within the University’s School of Engineering, is using GCMS-TD (gas chromatography, mass spectrometry and thermal desorption) technology to analyse the concentrations of volatile organic compounds (VOCs) in breath.

“Studies have shown that high concentrations of certain VOCs in breath can correlate with disease. For example, the odour of ‘pear drops’ esters and acetone in relation to diabetes, ammonia in relation to hepatitis, and dimethyl sulphide to cirrhosis. There are also certain compounds that seem to mark out particular types of cancer,' said Dr Yousef.

“If unique markers for specific diseases can be recognised earlier than traditional techniques, then there is immense potential to revolutionise early disease diagnosis before any symptoms have developed, and without the need for invasive procedures.”

The system works by analysing all the component chemicals and compounds that make up a patient’s breath. The GCMS-TD creates a breath profile, which allows scientists to identify VOCs that may signify the presence of disease.

Diagnostic techniques based on exhaled breath are much less developed than traditional blood or urine analysis techniques, and are not widely utilised in clinical practice. Such techniques have also previously been seen as crude, subjective and unreliable.

However, due to improved analytical methodology, volatile marker-based diagnostics offers new potential in the rapid diagnosis and monitoring of illnesses.

Dr Yousef believes that the breath test will provide a more convenient and rapid method for diagnosing serious diseases than blood or urine analysis, and will require minimal medical intervention.

“Breath samples are much easier to collect than blood and urine, for the patient as much as for the person collecting the sample. They can be collected anywhere by people with no medical training, and there are no associated biohazard risks,' said Dr Yousef.

“Overall, the procedure is likely to be much more cost effective than conventional methods, potentially saving the NHS a great deal of time and money.”

The research will lead to the development of simple diagnostic tools such as test strips that give positive results for specific illness markers, thereby reducing the cost and level of expertise for diagnosis.

Dr Timothy Claypole, director of the Welsh Centre for Printing and Coating, said: “Swansea University is undoubtedly taking a lead in the use of GCMS-TD to identify unique biomarkers in breath profiles.

“The work that we are doing now could well lead to the use of breath tests in routine medical examinations, long before patients show any physical symptoms. Ultimately, this technology will save lives.”

The GCMS-TD equipment has been funded by a grant from the Welsh Assembly Government Knowledge Exploitation Fund. The equipment was originally used to research the level of solvents and other VOCs inhaled by operators of printing machinery.


Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   Â© 2012 ProHealthServiceZone.com
Netgains Logo